Swedish snus for tobacco harm reduction - Authors' reply

Lancet

Volumn 370, Issue 9594, 2007, Pages 1206-1207

  Gartner, Coral E ^a   Hall, Wayne D ^a   Vos, Theo ^a   Bertram, Melanie Y ^a   Wallace, Angela L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; HARM REDUCTION; HEALTH BEHAVIOR; HUMAN; LETTER; MARKETING; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; SNUS;

EID: 34948819217     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61532-3     Document Type: Letter

References (4)

1. Ramström L., and Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 15 (2006) 210-214
2. Bolliger C., Zellweger J., Danielsson T., et al. Smoking reduction with oral nicotine inhalers: double-blind randomised clinical trial of efficacy and safety. BMJ 321 (2000) 329-333
3. Bolinder G., Alfredsson L., Englund A., and de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 84 (1994) 399-404
4. Houston C. Revealed: tobacco giant's secret new weapon in the age of smoking bans. The Age (July 27, 2007)